VT News

José Ramón de la Fuente

Ask VT AI
View News Summary
  • UK economy contracts again amid tariffs and taxes, raising concerns about the economic outlook.
  • FDA rejects Capricor's cell therapy for Duchenne cardiomyopathy, citing insufficient evidence, but the company plans to resubmit with new trial data.
  • JPMorgan plans to charge fintech firms fees for customer data access, disrupting their business models and impacting stock prices.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • UK economy contracts again amid tariffs and taxes, raising concerns about the economic outlook.
  • FDA rejects Capricor's cell therapy for Duchenne cardiomyopathy, citing insufficient evidence, but the company plans to resubmit with new trial data.
  • JPMorgan plans to charge fintech firms fees for customer data access, disrupting their business models and impacting stock prices.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from José Ramón de la Fuente

Top Topics

Trending in U.S.

World

Sport